This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: CRM, QCOM, LULU, ALTR

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Ampco-Pittsburgh (AP) downgraded to hold at TheStreet Ratings.

BP (BP) downgraded to hold at TheStreet Ratings.

Brocade (BRCD) downgraded at ThinkEquity from Buy to Hold, ThinkEquity said. $5 price target. Company is facing intense competition and get 24% of sales from Europe.

Comerica (CMA) upgraded at Stifel from Sell to Hold, Stifel Nicolaus said. Valuation call.

Fusion-IO (FIO) upgraded at Sterne Agee to Buy, Sterne Agee said. $24 price target. Company has pulled back to an attractive level and has positive, near-term growth drivers.

Marvell Technology (MRVL) upgraded at JMP from Underperform to Market Perform, JMP Securities said. Valuation call, despite recent weakness.

Vail Resorts (MTN) rated new Buy at Keybanc. Valuation call, based on a $60 price target.

Navistar (NAV) downgraded at Baird from Outperform to Neutral, Robert Baird said. $31 price target. Company faces numerous headwinds to growth.

Piedmont Natural Gas (PNY) upgraded at Baird from Neutral to Outperform, Robert Baird said. $33 price target. Company has invested into infrastructure and can generate above-average earnings growth for several years.

Portland General (POR) rated new Buy at Deutsche. $27.50 price target. Company is trading at a discount to its peers, but can deliver above-average growth.

Zions Bancorporation (ZION) upgraded at DA Davidson to Buy from Neutral, DA Davidson said. $22 price target. Pullback provides opportunity despite economic uncertainty.

STOCK COMMENTS / EPS CHANGES

Altera (ALTR - Get Report) numbers lowered at UBS. Shares of ALTR now seen reaching $40, UBS said. Estimates also lowered as weaker macro is likely to mute the recovery. Buy rating.

Auxilium Pharma (AUXL) target raised at Jefferies to $30, Jefferies said. Good buying opportunity on positive Peyronie's data. Buy rating.

Salesforce.com (CRM - Get Report) estimates lowered at UBS through 2014, UBS said. Details emerge on Buddy media acquisition. Buy rating and $190 price target.

Salesforce.com estimates reduced at BMO through 2014, BMO Capital said. Buddy Media purchase will cut into earnings. Outperform rating and $170 price target.

Dollar General (DG - Get Report) estimates increased at Morgan Stanley through 2014, Morgan Stanley said. Higher sales and productivity are driving wider margins. Equal-weight rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ALTR $41.33 1.10%
DG $76.53 -0.10%
CRM $68.71 1.30%
LULU $67.34 0.60%
QCOM $68.94 1.00%

Markets

DOW 18,157.13 +76.99 0.43%
S&P 500 2,124.25 +6.56 0.31%
NASDAQ 5,116.1860 +24.1010 0.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs